Impact of Neuropathic Post-Zosterian Pain on the Cognition

Impact of Neuropathic Post-zosterian Pain on the Cognition (NPZ and Cognition)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00989040

Enrollment

100

Registered

2009-10-02

Start date

2009-03-31

Completion date

2009-09-30

Last updated

2012-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition, Neuropathic Post-zosterian Pain

Keywords

NPZ, Pain

Brief summary

Pain is defined as a sensorial and emotional phenomenon and lead consequences on the cognition. These consequences could be increased with usual treatment. So the aim of this study is to explore these cognitive consequences.

Detailed description

Pilot prospective study with parallel groups

Interventions

DRUGusual treatment: Versatis

* To explore if the cognition is failed in treated patients suffering of neuropathic postzosteria pain. * To see if treated patients with patch (Versatis®) have better cognition than treated patients without patch.

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patient suffering of NPZ pain * Over 55 years old * Healthy volunteers

Design outcomes

Primary

Measure	Time frame
The principal outcome is to explore if the cognition is failed in treated patients suffering of neuropathic post-zosteria pain.	at day 1

Secondary

Measure	Time frame
Study if treated patients with patch (Versatis®) have better cognition than treated patients without patch.	at day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026